This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent. Top assignee: University of Virginia Patent Foundation. Active years: 2009.
Company Filing History:
Years Active: 2009
Title: Michael C Breadmore: Innovator in Nucleic Acid Purification
Introduction
Michael C Breadmore is a notable inventor based in Margate, Australia. He has made significant contributions to the field of nucleic acid purification through his innovative work. His research focuses on developing advanced methods and devices that enhance the efficiency of biological sample analysis.
Latest Patents
Michael C Breadmore holds a patent for an "Apparatus and method for the purification of nucleic acids." This invention is directed towards a novel device that comprises a sol-gel filled microchannel, which is designed for purifying nucleic acids from biological samples. The microfluidic device features a base with a microchannel formed in its interior, filled with a sol-gel matrix. It is in fluid communication with an inlet port and an outlet port, both located on the exterior surface of the base. This device may also include additional components to facilitate analytical analysis of the purified nucleic acid sequences. He has 1 patent to his name.
Career Highlights
Michael C Breadmore has been associated with the University of Virginia Patent Foundation, where he has contributed to various research initiatives. His work has been instrumental in advancing the methodologies used in nucleic acid purification, which is crucial for numerous applications in biotechnology and medical research.
Collaborations
Throughout his career, Michael has collaborated with esteemed colleagues, including James P Landers and Pamela E Norris. These collaborations have further enriched his research and contributed to the development of innovative solutions in his field.
Conclusion
Michael C Breadmore is a prominent figure in the realm of nucleic acid purification, with a focus on innovative devices and methods. His contributions continue to impact the scientific community positively.